Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
Clinical trial NCT00063297 · COMPLETED
Trial details
- NCT number
- NCT00063297
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.